Liver microphysiological platforms for drug metabolism applications
Introduction Liver microphysiological platforms for drug metabolism applications are the need of the hour to fix the exorbitant
Microphysiological System
Adipocyte heterogeneity underlying adipose tissue functions
Introduction Adipose tissue functions are not only to store energy, it also governs the metabolism of
Perilipin 5 links mitochondrial uncoupled respiration in brown fat to healthy white fat remodeling and systemic glucose tolerance (Gallardo-Montejano et al, 2021)
Introduction According to a recent study headed by UT Southwestern researchers, increasing a protein contained in
Rebuilding the Vascular Network: In vivo and in vitro Approaches (Meng et al, 2021)
Introduction The vascular network carries the transportation of materials and nutrients as the fluid delivery mechanism
Experimental liver models: from cell culture techniques to microfluidic organs-on-chip (Polidoro et al, 2021)
Introduction The Organ-on-a-Chip (OOAC) is a leading organ biomimetic (POB) device based on a microfluidic chip in the
Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis (Collins DP et al, 2021)
Introduction SARS-CoV-2 is the virus that caused the COVID-19 pandemic and its devastating effects on global
Insulin action in adipocytes, adipose remodeling, and systemic effects (Santoro et al, 2021)
Introduction (Santoro et al) recognizes the essential importance adipocytes which react exquisitely to insulin have played in determining the mechanisms
OOCHIP: Compartmentalized Microfluidic Perfusion System with Porous Barriers for Enhanced Cell-Cell Crosstalk in Organ-on-a-Chip (Ramadan et al)
Abstract (Ramadan et al) : Improved in vitro models of human organs for predicting drug efficacy, interactions, and
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Introduction In the New England Journal of Medicine, a recent study found significant weight loss with
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
Adiponectin and Diabetes One-third of Americans are expected to have diabetes by 2050. Understanding how to
get in touch
Get the best insights about Cherry Biotech by Email
Let’s stay in touch!
